Kyntra Bio, Inc.
KYNB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000921299
No open-market purchases or sales by Kyntra Bio, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $7.54M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Kyntra Bio, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −4 vs. Q1 2026
- Shares held
- 999.0K
- −35.7K (−3.5%) vs. Q1 2026
- Total value
- $7.54M
- +$527.1K (+7.5%) vs. Q1 2026
- New holders
- 1
- 6 more added
- Sold out
- 5
- 8 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $7.54M |
| Q1 2026 | 32 | $7.01M |
| Q4 2025 | 34 | $10.1M |
| Q3 2025 | 32 | $13.9M |
| Q2 2025 | 30 | $5.62M |
| Q1 2025 | 56 | $10.2M |
| Q4 2024 | 70 | $19.2M |
| Q3 2024 | 72 | $18.3M |
| Q2 2024 | 102 | $50.4M |
| Q1 2024 | 111 | $143.9M |
| Q4 2023 | 100 | $62.1M |
| Q3 2023 | 110 | $59.0M |
| Q2 2023 | 153 | $207.9M |
| Q1 2023 | 173 | $1.42B |
| Q4 2022 | 145 | $1.20B |
| Q3 2022 | 152 | $950.1M |
| Q2 2022 | 152 | $746.9M |
| Q1 2022 | 158 | $816.6M |
| Q4 2021 | 164 | $934.6M |
| Q3 2021 | 165 | $656.8M |
| Q2 2021 | 176 | $1.80B |
| Q1 2021 | 199 | $2.47B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Kyntra Bio, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Smithfield Trust Co | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 1 | $8 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 12 | $88 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 46 | $347 | 0.00% | −4−8.0% | Reduced |
| Royal Bank of Canada | 138 | $1.00K | 0.00% | +1+0.7% | Added |
| SBI Securities Co., Ltd. | 152 | $1.15K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 182 | $1.37K | 0.00% | +2+1.1% | Added |
| National Bank of Canada | 193 | $1.45K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 200 | $1.51K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 487 | $3.68K | 0.00% | −1−0.2% | Reduced |
| Axiom Investment Management LLC | 704 | $5.32K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,113 | $8.40K | 0.00% | +781+235.2% | Added |
| Vanguard Global Advisers, LLC | 1,424 | $10.8K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 4,406 | $33.3K | 0.00% | −86−1.9% | Reduced |
| UBS Group AG | 7,857 | $59.3K | 0.00% | −19,734−71.5% | Reduced |
| Gsa Capital Partners LLP | 15,697 | $119.0K | 0.01% | +15,697 | New |
| State Street Corp | 20,284 | $153.1K | 0.00% | 00.0% | Unchanged |
| Birchview Capital, LP | 22,566 | $170.4K | 0.08% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 24,105 | $182.0K | 0.00% | +163+0.7% | Added |
| Renaissance Technologies LLC | 27,081 | $204.5K | 0.00% | −400−1.5% | Reduced |
| Two Sigma Investments, LP | 39,511 | $298.3K | 0.00% | −10,000−20.2% | Reduced |
| HighTower Advisors, LLC | 39,746 | $300.1K | 0.00% | +20.0% | Added |
| Geode Capital Management, LLC | 43,219 | $326.4K | 0.00% | −2,779−6.0% | Reduced |
| BlackRock, Inc. | 84,330 | $636.7K | 0.00% | −10.0% | Reduced |
| Acadian Asset Management LLC | 105,585 | $795.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 159,950 | $1.21M | 0.00% | +3,343+2.1% | Added |
| Armistice Capital, LLC | 400,000 | $3.02M | 0.08% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,228−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −10,469−100.0% | Sold out |
| CFG Wealth Management Services, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |